Are you looking for a higher-quality, faster-time to market manufacturing solution for your protein therapeutic? Learn how AbSci’s Protein PrintingTM technology has revolutionized biomanufacturing and enabled production of high quality, complex therapeutic proteins in E. coli SoluPro®.

Topics covered include:

• Cell line design and cell screening strategies to optimize expression for antibodies and difficult-to-express proteins
• Cell line scalability and protein titer and quality metrics that meet pharma standards
• Unprecedented cell line development speed enabled by a synthetic biology-driven workflow that meets timeline needs for COVID-19 therapeutics
• Opportunities to simultaneously perform protein discovery and assess biomanufacturability